-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Connect Biopharma Hldgs, Lowers Price Target to $5

Benzinga·11/17/2026 14:22:25
Listen to the news
Piper Sandler analyst Biren Amin maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight and lowers the price target from $7 to $5.